Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
41,696,731
-
Shares change
-
+2,028,888
-
Total reported value, excl. options
-
$352,475,779
-
Value change
-
+$19,667,118
-
Put/Call ratio
-
32%
-
Number of buys
-
83
-
Number of sells
-
-83
-
Price
-
$8.82
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2025
210 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q3 2025.
Emergent BioSolutions Inc. - Common Stock (EBS) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,696,731 shares
of 54,486,781 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (4,263,123 shares), OAK HILL ADVISORS LP (3,613,338 shares), VANGUARD GROUP INC (3,540,670 shares), STATE STREET CORP (2,445,759 shares), AMERICAN CENTURY COMPANIES INC (2,382,378 shares), DIMENSIONAL FUND ADVISORS LP (2,140,340 shares), PALISADE CAPITAL MANAGEMENT, LP (1,426,019 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1,381,750 shares), GEODE CAPITAL MANAGEMENT, LLC (1,278,693 shares), and ACADIAN ASSET MANAGEMENT LLC (1,177,661 shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.